Literature DB >> 170076

Nervous system degeneration produced by acrylamide monomer.

P S Spencer, H H Schaumburg.   

Abstract

Acrylamide, widely employed as a vinyl monomer in the polymer industry, is a potent neurotoxin to man and to animals. The cumulative effect of prolonged, low-level exposure to acrylamide monomer is the insidious development of a progressive peripheral neuropathy. Sensory symptoms begin in the hands and feet (numbness, pins and needles), certain reflexes are lost and, with severe exposure, muscle weakness and atrophy occur in the extremities. The peripheral neuropathy may be supplemented by symptoms indicative of central nervous system damage (ataxia, tremor, somnolence and mental changes). The neuropathologic basis for this clinical picture has been determined in cats. Here, chronic acrylamide intoxication produces selective peripheral and central nerve fiber degeneration. Degeneration first occurs in the extremities of long and large nerve fibers which later undergo a progressive, seriate proximal axonal degeneration known as dying-back. Especially vulnerable are sensory axons supplying Pacinian corpuscles and muscle spindles in the hindfoot toepads, while adjacent motor nerve axons die back later. Distal central nerve fiber degeneration is seen in the medulla and the cerebellum. The neurotoxic property of acrylamide is of practical concern in two areas. One major problem is the protection of factory workers engaged in the manufacture of acrylamide. A sensitive test of neurologic function in these individuals, i.e., touch sensation, based on the experimental observation of the exquisite vulnerability of Pacinian corpuscles in acrylamide intoxicated cats, is presently under consideration. The second area for concern is the exposure of the populace to minute amounts of neurotoxic acrylamide monomer which contaminate acrylamide polymers currently deployed in the environment. Federal restrictions on the maximum permitted exposure to acrylamide, based on a largely clinical study of acrylamide neurotoxicity conducted ten years ago, may require a re-evaluation in the light of recent advances which have pinpointed the initial sites of nerve fiber degeneration.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 170076      PMCID: PMC1475186          DOI: 10.1289/ehp.7511129

Source DB:  PubMed          Journal:  Environ Health Perspect        ISSN: 0091-6765            Impact factor:   9.031


  25 in total

1.  Nervous system degeneration produced by the industrial solvent methyl n-butyl ketone.

Authors:  P S Spencer; H H Schaumburg; R L Raleigh; C J Terhaar
Journal:  Arch Neurol       Date:  1975-04

Review 2.  ORGANO-PHOSPHORUS NEUROTOXICITY: A MODEL "DYING BACK" PROCESS COMPARABLE TO CERTAIN HUMAN NEUROLOGICAL DISORDERS.

Authors:  J B CAVANAGH
Journal:  Guys Hosp Rep       Date:  1963

3.  Axoplasmic flow in axonal neuropathies. I. Axoplasmic flow in cats with toxic neuropathies.

Authors:  W G Bradley; M H Williams
Journal:  Brain       Date:  1973-06       Impact factor: 13.501

4.  Alteration of amino acid incorporation into proteins of the nervous system in vitro after administration of acrylamide to rats.

Authors:  K Hashimoto; K Ando
Journal:  Biochem Pharmacol       Date:  1973-05-01       Impact factor: 5.858

5.  Physiologic and pathologic changes in acrylamide neuropathy.

Authors:  R J Leswing; W E Ribelin
Journal:  Arch Environ Health       Date:  1969-01

6.  Electrophysiological and histological observations on peripheral nerves in acrylamide poisoning in man.

Authors:  P M Fullerton
Journal:  J Neurol Neurosurg Psychiatry       Date:  1969-06       Impact factor: 10.154

7.  Six cases of acrylamide poisoning.

Authors:  T O Garland; M W Patterson
Journal:  Br Med J       Date:  1967-10-28

8.  Peripheral neuropathy in rats produced by acrylamide.

Authors:  P M Fullerton; J M Barnes
Journal:  Br J Ind Med       Date:  1966-07

9.  The effect of acrylamide on the peripheral nervous system of the baboon.

Authors:  A Hopkins
Journal:  J Neurol Neurosurg Psychiatry       Date:  1970-12       Impact factor: 10.154

10.  Peripheral neuropathy with sympathetic overactivity from industrial contact with acrylamide.

Authors:  R B Auld; S F Bedwell
Journal:  Can Med Assoc J       Date:  1967-03-18       Impact factor: 8.262

View more
  8 in total

Review 1.  Photochemical approaches to vision restoration.

Authors:  Russell N Van Gelder
Journal:  Vision Res       Date:  2015-02-11       Impact factor: 1.886

2.  Case Files of the Medical Toxicology Fellowship at the Oregon Poison Center: Thallotoxicosis.

Authors:  Matthew S Correia; Annette M Lopez
Journal:  J Med Toxicol       Date:  2022-03-10

3.  The acrylamide content of smokeless tobacco products.

Authors:  Kevin McAdam; Harriet Kimpton; Carl Vas; David Rushforth; Andrew Porter; Brad Rodu
Journal:  Chem Cent J       Date:  2015-10-12       Impact factor: 4.215

4.  Observation of Enhanced Dissociative Photochemistry in the Non-Native Nucleobase 2-Thiouracil.

Authors:  Kelechi O Uleanya; Rosaria Cercola; Maria Nikolova; Edward Matthews; Natalie G K Wong; Caroline E H Dessent
Journal:  Molecules       Date:  2020-07-10       Impact factor: 4.411

Review 5.  Peripheral Neuropathic Pain: From Experimental Models to Potential Therapeutic Targets in Dorsal Root Ganglion Neurons.

Authors:  Ti-Yen Yeh; I-Wei Luo; Yu-Lin Hsieh; To-Jung Tseng; Hao Chiang; Sung-Tsang Hsieh
Journal:  Cells       Date:  2020-12-21       Impact factor: 6.600

Review 6.  The Mechanism of Acrylamide-Induced Neurotoxicity: Current Status and Future Perspectives.

Authors:  Mengyao Zhao; Boya Zhang; Linlin Deng
Journal:  Front Nutr       Date:  2022-03-25

7.  An exploratory identification of biological markers of chronic musculoskeletal pain in the low back, neck, and shoulders.

Authors:  Codjo Djignefa Djade; Caroline Diorio; Danielle Laurin; Clermont E Dionne
Journal:  PLoS One       Date:  2022-04-15       Impact factor: 3.752

8.  Negative association between acrylamide exposure and body composition in adults: NHANES, 2003-2004.

Authors:  P-L Chu; L-Y Lin; P-C Chen; T-C Su; C-Y Lin
Journal:  Nutr Diabetes       Date:  2017-03-13       Impact factor: 5.097

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.